World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
81
Citations
44917
World Ranking
16373
National Ranking
8239

Overview

Ross C. Donehower is affiliated with Johns Hopkins University in the United States and has contributed extensively to the field of Medicine, with a particular focus on Oncology. Their research spans multiple subfields including Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research, Molecular Biology, and Public Health, Environmental and Occupational Health.

Their recent publications cover diverse topics in cancer research and clinical oncology. Notable papers include:

  • An International Phase 2 Study of Pazopanib in Progressive and Metastatic Thyroglobulin Antibody Negative Radioactive Iodine Refractory Differentiated Thyroid Cancer, 2020, published in Thyroid
  • Challenges of the current precision medicine approach for pancreatic cancer: A single institution experience between 2013 and 2017, 2020, published in Cancer Letters
  • RAD51B Harbors Germline Mutations Associated With Pancreatic Ductal Adenocarcinoma, 2022, published in JCO Precision Oncology
  • Geographic disparities in breast cancer mortality and place of death in the United States from 2003 to 2019, 2022, published in Journal of Clinical Oncology
  • Hematology/medical oncology fellow responses to the initial development of an antiracism curriculum, 2021, published in Journal of Clinical Oncology

Donehower has frequently collaborated with a number of co-authors across their publications. Notable frequent co-authors include:

  • Kristen A. Marrone
  • Ana De Jesus-Acosta
  • Dung T. Le
  • Robert A. Anders
  • Daniel A. Laheru

The scientist's work is published predominantly in journals with a strong focus on clinical oncology and cancer research. These frequent publication venues comprise:

  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Thyroid
  • Cancer Letters
  • JCO Precision Oncology

Key topics explored in Donehower's research include:

  • Advances in Oncology and Radiotherapy
  • Cancer Genomics and Diagnostics
  • Global Cancer Incidence and Screening
  • Economic and Financial Impacts of Cancer
  • Pancreatic and Hepatic Oncology Research
  • Genetic factors in colorectal cancer
  • Colorectal Cancer Treatments and Studies

Best Publications

  • PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

    Dung T. Le;Jennifer N. Uram;Hao Wang;Bjarne R. Bartlett

  • Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

    Dung T. Le;Dung T. Le;Jennifer N. Durham;Jennifer N. Durham;Kellie N. Smith;Hao Wang

  • Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms.

    William P. McGuire;Eric K. Rowinsky;Neil B. Rosenshein;Francis C. Grumbine

  • Taxol: A Novel Investigational Antimicrotubule Agent

    Eric K. Rowinsky;Lorranie A. Cazenave;Ross C. Donehower

  • Hypersensitivity reactions from taxol.

    R B Weiss;R C Donehower;P H Wiernik;T Ohnuma

  • Clinical toxicities encountered with paclitaxel (Taxol)

    Rowinsky Ek;Eisenhauer Ea;Chaudhry;Arbuck Sg

  • The Current Status of Camptothecin Analogues as Antitumor Agents

    William J. Slichenmyer;Eric K. Rowinsky;Ross C. Donehower;Scott H. Kaufmann

  • Novel Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Tumor Vaccine for Pancreatic Cancer: A Phase I Trial of Safety and Immune Activation

    Elizabeth M. Jaffee;Ralph H. Hruban;Barbara Biedrzycki;Daniel Laheru

  • Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer

    Philip A. Philip;Michelle R. Mahoney;Cristine Allmer;James Thomas

  • Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer.

    Dung T. Le;Eric Lutz;Jennifer N. Uram;Elizabeth A. Sugar

  • Cardiac disturbances during the administration of taxol.

    Eric K. Rowinsky;William P. McGuire;Thomas Guarnieri;Jason S. Fisherman

  • The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics.

    Eric K. Rowinsky;Ross C. Donehower

  • Peripheral neuropathy from taxol and cisplatin combination chemotherapy: Clinical and electrophysiological studies

    Vinay Chaudhry;Vinay Chaudhry;Eric K. Rowinsky;Susan E. Sartorius;Ross C. Donehower

  • Microtubule changes and cytotoxicity in leukemic cell lines treated with taxol.

    Eric K. Rowinsky;Ross C. Donehower;Richard J. Jones;Robert W. Tucker

  • Analysis of Fluorouracil-Based Adjuvant Chemotherapy and Radiation After Pancreaticoduodenectomy for Ductal Adenocarcinoma of the Pancreas: Results of a Large, Prospectively Collected Database at the Johns Hopkins Hospital

    Joseph M. Herman;Michael J. Swartz;Charles C. Hsu;Jordan Winter

  • Interventions for preventing neuropathy caused by cisplatin and related compounds

    James W Albers;Vinay Chaudhry;Guido Cavaletti;Ross C Donehower

  • Phase II Study of Erlotinib in Patients With Advanced Biliary Cancer

    Philip A. Philip;Michelle R. Mahoney;Cristine Allmer;James Thomas

  • Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study.

    Timothy Iveson;Ross C Donehower;Irina Davidenko;Sergey Tjulandin

  • Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001

    Sharyn D. Baker;Jaap Verweij;Eric K. Rowinsky;Ross C. Donehower

  • PD-1 blockade in tumors with mismatch repair deficiency.

    Dung T. Le;Jennifer N. Uram;Hao Wang;Bjarne Bartlett

Frequent Co-Authors

Eric K. Rowinsky
Eric K. Rowinsky Eli Lilly (United States)
David S. Ettinger
David S. Ettinger Johns Hopkins University
Sharyn D. Baker
Sharyn D. Baker The Ohio State University
Manuel Hidalgo
Manuel Hidalgo Cornell University
Luis A. Diaz
Luis A. Diaz Memorial Sloan Kettering Cancer Center
Antonio Jimeno
Antonio Jimeno University of Colorado Boulder
Wells A. Messersmith
Wells A. Messersmith University of Colorado Boulder
Ralph H. Hruban
Ralph H. Hruban Johns Hopkins University School of Medicine
Michael A. Carducci
Michael A. Carducci Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring a career in medicine in the USA but want alternative or accelerated routes, several online degrees open doors to healthcare professions. Registered nurses can further their education and career opportunities through rn to bsn programs. Many of these are designed to be flexible, and some do not involve traditional clinical requirements, which suits working professionals.

Licensed practical nurses interested in advancing can benefit from lpn programs that offer fast-track options online, helping you step into the workforce sooner. For nurses aiming to reach top leadership or advanced clinical roles, a Doctor of Nursing Practice (DNP) degree is highly valued. Dnp programs are available online, and there are resources highlighting flexible, accessible options.

If you have a master’s degree, the shortest msn to dnp program can help you achieve a doctoral credential quickly, advancing your qualifications and earning potential. Each of these pathways offers flexible study options, making it easier for busy professionals or career changers to take the next step in healthcare.

Best Scientists Citing Ross C. Donehower

Trending Scientists